A Rationally-Designed Chimeric KDM1A/KDM1B Histone Demethylase Tower Domain Deletion Mutant Retaining Enzymatic Activity

FEBS Letters - United States
doi 10.1016/j.febslet.2015.07.028
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Targeting Histone Demethylase LSD1/KDM1a in Neurodegenerative Diseases

Journal of Experimental Neuroscience
Neuroscience
2018English

Antibacterial Activity of Rationally Designed Antimicrobial Peptides

International Journal of Microbiology
Microbiology
2020English

A Rationally Designed A34R Mutant Oncolytic Poxvirus: Improved Efficacy in Peritoneal Carcinomatosis

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2013English

Rationally Designed Tularemia Vaccines

Expert Review of Vaccines
Molecular MedicineDrug DiscoveryImmunologyPharmacology
2009English

Geldanamycin Inhibits Jumonji Histone Lysine Demethylase KDM4 and Targets Chimeric Transcription Factor PAX3-FOXO1

2019English

Rationally Designed Complex, Hierarchical Microarchitectures

Science
MultidisciplinaryPhilosophy of ScienceHistory
2013English

Chemoprobe-Based Assays of Histone Lysine Demethylase 1A Target Occupation Enable in Vivo Pharmacokinetics and -Dynamics Studies of KDM1A Inhibitors

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2019English

Inhibition of the Histone Demethylase KDM4B Leads to Activation of KDM1A, Attenuates Bacterial-Induced Pro-Inflammatory Cytokine Release, and Reduces Osteoclastogenesis

Epigenetics
Cancer ResearchMedicineMolecular Biology
2018English

Deferiprone: Pan-Selective Histone Lysine Demethylase Inhibition Activity and Structure Activity Relationship Study

Scientific Reports
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy